Offering Unparalleled Resolution and Quality in Microbial
Analysis
COPENHAGEN, Denmark, April 23,
2024 /PRNewswire/ -- Clinical Microbiomics, a
leader in microbiome analysis, announces the launch of its advanced
long-read sequencing services. Tailored to meet the stringent
requirements of academic, clinical, and industrial researchers, the
expanded offerings deliver unmatched insights into microbial
communities, featuring the industry's highest quality scores and
read lengths.
Anders Grøn, CEO, states, "Our enhanced long-read sequencing
capabilities are redefining the standards in microbial analysis and
microbiome research. By broadening our range to include 16S, ITS,
18S rRNA, custom gene sequencing, and comprehensive genomics and
metagenomics, we offer a more extensive and innovative perspective
on microbial ecosystems. This advancement marks a revolutionary
step in our ability to understand and leverage microbial
interactions within the realms of health, disease, and
environmental studies."
Manoj Dadlani, CCO and Chairman,
adds, "The acquisition of DNASense, co-founded by Profs.
Mads Albertsen and Per Halkjær
Nielsen, esteemed members of the Oxford Nanopore Technologies (ONT)
developer community, has been crucial in boosting our sequencing
and analytical capabilities. DNASense's unique expertise enables us
to consistently deliver the market's highest-quality long-read
data, establishing new standards for reliability and precision in
microbial sequencing."
Service Features Include:
- Longer Reads: producing the longest reads possible from
any microbiome sample, enabling detailed analysis of complex
microbial communities and aiding in the creation of closed genomes
for comprehensive mapping.
- High-Quality Scores: providing unmatched data quality,
which significantly decreases the necessity for re-sequencing and
speeds up the research process. The high-quality data also enable
confident identification of modified bases, leading to more precise
gene annotation and marker gene analysis.
- Multi-Omics Capabilities: integrating long-read
sequencing with (meta)transcriptomics and metabolomics, the company
offers unparalleled resolution for both isolates and complete
microbiomes. This approach supports unbiased native DNA sequencing
and superior data utilization due to higher quality
assemblies.
- Comprehensive Workflow:End-to-end workflows include
long-read compatible DNA extractions, customized sequencing library
preparation, and sequencing using the ONT P24 platform, complete
with the latest signal processing algorithms.
- Advanced Bioinformatics: employs advanced de novo
bioinformatics pipelines optimized for long-read data to ensure
high contiguity metagenomics and improved binning, leading to
transformative insights for research and development.
- User-Friendly Software: allows for intuitive result
exploration, enhancing the user experience and facilitating
efficient data interaction, which leads to extremely fast
turnaround times and the potential for rapid scientific
discoveries.
Marianne Koliana, VP of Business Development, will present
Clinical Microbiomics' new long-read sequencing capabilities at the
12th Microbiome, Probiotics & Prebiotics R&D and Business
Collaboration Forum in The Hague,
Netherlands, on Wednesday, April
24th. The forum will offer an in-depth look at the company's
cutting-edge services and provide opportunities for direct
engagement with its expert team.
Dr. Henrik Bjørn Nielsen, Chief Scientific Officer, states, "Our
new long-read sequencing services represent a significant
advancement in microbiome research. The ability to generate longer
reads equips us to provide microbial community insights at a much
higher resolution. This precision not only aids in distinguishing
between closely related organisms but also significantly enhances
our capability to link specific functions to these organisms.
Furthermore, the depth of data we collect supports the construction
of high-quality metagenome-assembled genomes, offering our clients
a clearer and more complete picture of the microbial
ecosystem."
Clinical Microbiomics' long-read sequencing services are
globally available, supported by state-of-the-art laboratories in
Denmark and the United States. The recent merger with
CosmosID has expanded the company's global reach, enabling the
provision of advanced services to an extensive international
clientele and promoting scientific advancement worldwide.
For inquiries, contact Sidney
Hooker, 7869428815, 376620@email4pr.com
About Clinical Microbiomics:
Clinical Microbiomics was founded in 2015 by Professor
Morten Sommer and co-founder
Rasmus Toft-Kehler, PhD. Read more
here.
View original
content:https://www.prnewswire.com/news-releases/clinical-microbiomics-launches-advanced-long-read-16s-its-18s-isolate-and-metagenomics-sequencing-services-302124618.html
SOURCE Clinical Microbiomics